← all works
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Machine scores (provisional)
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Opus teacher head0.183
GPT teacher head0.413
- Teacher spread
- 0.230 · how far apart the two teachers sit on this one work
- Validation status
score_only:v0-immature-baseline· verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it
Abstract
Peer Reviewed
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Arthritis Care & Research
- Topic
- Rheumatoid Arthritis Research and Therapies
- Field
- Medicine
- Canadian institutions
- Bombardier (Canada)Toronto General Hospital
- Funders
- National Center for Research ResourcesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesUniversity of Alabama at BirminghamAstraZenecaPfizerUniversity of AlabamaBiogenAbbott CanadaU.S. Department of Veterans Affairs
- Keywords
- Rheumatoid arthritisMedicineAntirheumatic drugsRheumatologyAntirheumatic AgentsInternal medicineDiseaseAlternative medicineBiologic AgentsPhysical therapyPathology
- Has abstract in OpenAlex
- yes